Secondary Logo

Journal Logo

Institutional members access full text with Ovid®

Myopic LASIK in Psychiatric Patients

Ortega-Usobiaga, Julio MD, PhD; García-Sáenz, María Carmen MD, PhD; Artaloytia-Usobiaga, Juan F MD, PhD; Llovet-Osuna, Fernando MD, PhD; Beltrán-Sanz, Jaime MD; Baviera-Sabater, Julio MD

doi: 10.1097/ICO.0b013e3182215a36
Clinical Science

Purpose: To evaluate the surgical results obtained in patients with psychiatric disorders who underwent myopic laser in situ keratomileusis. (LASIK).

Methods: Retrospective study of 156 eyes of 82 patients who underwent LASIK to correct a myopic spherical equivalent (SE) at Clínica Baviera–Instituto Oftalmolo´gico Europeo, Bilbao, Spain. All procedures were performed with the Technolas Keracor 217 Z excimer laser. Patients had a preoperative diagnosis of bipolar disorder (79 eyes of 42 patients), schizophrenia (61 eyes of 32 patients), or obsessive–compulsive disorder (16 eyes of 8 patients). Before surgery, the average sphere of the series was −3.92 ± 2.24 D in the first group, −3.45 ± 2.03 D in the second group, and −3.39 ± 1.97 D in the third group. We surveyed the patients to analyze subjective assessment from the patient's perspective.

Results: At the last available visit after treatment, we obtained an SE of ±0.50 D in 85.71% of eyes with bipolar disorder, 88.52% of eyes with schizophrenia, and 93.75% of eyes with obsessive–compulsive disorder. The efficacy index was 1.00 ± 0.20 in the first group, 1.03 ± 0.21 in the second group, and 1.00 ± 0.07 in the third group. No eye lost 2 lines or more of best spectacle–corrected visual acuity.

Conclusions: We found that patients with compensated psychiatric disorders, of which the surgeon was aware, achieved excellent results after surgery, with no remarkable complications. Patients tolerated the procedures well and were satisfied.

From *Clínica Baviera-Instituto Oftalmológico Europeo, Bilbao; †Hospital Fundación Alcorcón, Madrid; and ‡Private Practice, Billbao, Spain.

Received for publication January 5, 2011; revision received April 18, 2011; accepted April 24, 2011.

Supported by the Clínica Baviera-Instituto Oftalmológico Europeo, Spain.

Presented at the 1st Meeting of the Spanish Association of Technology and Implant, Refractive and Corneal Surgery (ASETCIRC), January 29–30, 2010, Madrid, Spain.

The authors state that they have no financial or conflicts of interest to disclose.

Reprints: Julio Ortega-Usobiaga, Clínica Baviera-Instituto Oftalmológico Europeo, Ibáñez de Bilbao, 9. Bilbao 48009, Bizkaia, Spain (e-mail:

Copyright © 2012 Wolters Kluwer Health, Inc. All rights reserved.